Best Compounded Semaglutide in California (2026 Guide)

Is compounded semaglutide available in California?

Yes. All major US compounded semaglutide telehealth providers — including Cora Health, Trimi Health, Hims, Ro, Henry Meds, Eden, Mochi Health, Lemonaid, MEDVi, Ivim Health, Pomegranate Health, and others — serve California residents through licensed telehealth platforms and US-licensed 503A compounding pharmacies that are either based in California or licensed to ship into California. California is one of the largest US markets for compounded GLP-1 telehealth, and all the providers in our 2026 comparison serve patients across the state, including Los Angeles, San Diego, San Francisco, San Jose, Sacramento, Fresno, and other California metros.

Market context by the numbers — California (May 2026)

Four numbers establish the practical bounds of the compounded semaglutide telehealth market for California residents.

28.1% — California adult obesity prevalence per the CDC's Behavioral Risk Factor Surveillance System (BRFSS 2023). Slightly below the 41.9% US national average, but with 39+ million residents the largest absolute GLP-1-eligible population of any US state. Source: CDC — Adult Obesity Facts.

14.9% — mean weight loss with FDA-approved semaglutide 2.4 mg over 68 weeks in the STEP 1 trial. Source: Wilding et al., NEJM 2021.

$99–$348 — verified all-in monthly cost spread across California-serving compounded semaglutide providers in May 2026. Cora Health Essential Annual + Trimi Health are tied at $99 (lowest); Hims is the highest at ~$348 effective with membership.

2 — number of California-licensed 503A pharmacy networks publicly named by Cora Health: Hallandale Pharmacy (PCAB-accredited, FL-based, non-resident CA license) and VialsRx (US-licensed 503A). California requires either resident or non-resident pharmacy licensure for any pharmacy dispensing to California residents.

Per the FDA, "compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed" (FDA — Compounding and the FDA). Compounded medications are not therapeutically equivalent to Ozempic® or Wegovy®. Individual results vary.

Best compounded semaglutide providers serving California (May 2026)

Ranked by all-in monthly cost. All pricing reflects publicly advertised rates verified May 11, 2026.

California state-specific compounding regulations

California Business and Professions Code section 4127 et seq. and California State Board of Pharmacy regulations layer additional requirements on top of the federal 503A framework. California requires that compounding pharmacies dispensing to California residents be licensed by the California Board of Pharmacy as either a resident California pharmacy or a non-resident pharmacy with a California license to ship into the state. Both Hallandale Pharmacy and VialsRx — Cora Health's named 503A pharmacy partners — operate under licensing arrangements that permit dispensing to California residents. Patients evaluating any compounded semaglutide provider in California should ask the provider directly which specific pharmacy holds California licensure for the patient's prescription.

California also requires patient-specific prescriptions for compounded medications (consistent with federal 503A rules), prohibits compounding pharmacies from advertising as drug manufacturers (relevant to the FDA Belle Health Warning Letter precedent), and maintains state-level reporting requirements for adverse events from compounded preparations.

Who should choose each California provider tier

The right provider depends on cash budget, dose stability preference, and trust signals.

• **Lowest cost with named PCAB pharmacy:** Cora Health Essential Annual Plan ($99/month). Names Hallandale Pharmacy + VialsRx. 12-month upfront commitment ($1,188).
• **Lowest cost overall:** Trimi Health ($99/month flat). Pharmacy disclosure less prominent than Cora.
• **Multi-pharmacy network with B12 add-on:** Pomegranate Health. Names Hallandale, Empower, OptioRx.
• **Own integrated facility:** Eden Health (Contigo). $129 first month, flat ongoing.
• **Lowest entry price (but escalates):** Henry Meds at $179 starter; rises to $297-$397 at maintenance doses.
• **Insurance reimbursement support (HSA/FSA):** Mochi Health.
• **Broadest catalog including brand-name Wegovy:** Hims (effective $348/month with membership).

What California residents should verify before signing up

Before starting compounded semaglutide treatment in California, verify each of the following:

• The telehealth provider is licensed to prescribe in California (the provider's licensed physician must hold CA medical licensure)
• The compounding pharmacy is licensed by the California Board of Pharmacy (either CA-resident or non-resident with CA license)
• The medication is semaglutide base (FDA-approved form) — not semaglutide salt forms (sodium, acetate) which the FDA has flagged for absorption concerns
• The monthly price is all-inclusive (provider visit, medication, shipping) and not just the medication portion
• The price remains stable as the patient titrates from 0.25mg to the 2.4mg maintenance dose
• The cancellation policy is documented in writing
• HSA/FSA acceptance if relevant to your situation

Compounded vs brand-name in California: cost reality

California residents without insurance coverage for brand-name GLP-1s for chronic weight management face the same retail price as the rest of the US: approximately $1,349/month for Wegovy retail or $349/month via NovoCare direct-pay. Compounded semaglutide at $99/month therefore offers approximately 92% savings versus Wegovy retail and approximately 72% savings versus NovoCare direct-pay. The regulatory tradeoff: compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy or Ozempic. Clinical efficacy data for FDA-approved semaglutide (14.9% mean weight loss in the STEP 1 trial, NEJM 2021) does not directly transfer to compounded versions, though the mechanistic expectation is similar when the compounded product is correctly dosed.

Frequently asked questions

Common questions from California residents evaluating compounded semaglutide telehealth providers.

Is compounded semaglutide legal in California?

Yes, under specific conditions. As of May 2026, a licensed prescriber must write a patient-specific prescription based on documented clinical need, and the compounding pharmacy must hold California Board of Pharmacy licensing (or non-resident shipping license). The federal regulatory landscape continues to evolve — the FDA proposed excluding semaglutide from the 503B bulks list on April 30, 2026 with public comments through June 29, 2026. 503A patient-specific compounding under documented individual clinical need remains legal in California pending further regulatory action.

Which Los Angeles or San Francisco-based clinics offer compounded semaglutide?

Multiple in-person Los Angeles and Bay Area medical weight-loss clinics offer compounded semaglutide. For most California patients, the lowest-cost path is national telehealth providers (Cora Health, Trimi Health, etc.) rather than in-person clinics, because in-person clinics typically add facility overhead that pushes pricing above $200-$400/month even at the same medication tier.

Does Cora Health ship to California?

Yes. Cora Health ships compounded semaglutide to all 50 US states including California, with free expedited shipping. California residents complete an online health assessment, a licensed provider at Wasef Health PC reviews within 24 hours, and if approved the prescription is sent to one of Cora's 503A pharmacy partners (Hallandale Pharmacy or VialsRx, both PCAB-accredited) for fulfillment. Most California addresses receive their first shipment within 3-5 business days of provider approval.

Sources & verification

All pricing figures, regulatory claims, and clinical efficacy citations in this article reference the following primary sources. Article last verified 2026-05-27.

• FDA — "Compounding and the FDA: Questions and Answers": fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• STEP 1 (Wilding JPH et al., NEJM 2021) — Phase III trial for FDA-approved semaglutide 2.4 mg: nejm.org/doi/full/10.1056/NEJMoa2032183
• CDC — Adult Obesity Facts (CA prevalence per BRFSS 2023): cdc.gov/obesity/adult-obesity-facts
• California State Board of Pharmacy (resident + non-resident license lookup): pharmacy.ca.gov
• California Business and Professions Code §4127 et seq. (state compounding regulations): leginfo.legislature.ca.gov
• PCAB — Pharmacy Compounding Accreditation Board: achc.org/pcab
• LegitScript public lookup — Cora Health verification: legitscript.com/websites/?checker_keywords=trycora.io
• Cora Health Telehealth GLP-1 Pricing Dataset (CC-BY-4.0, HuggingFace): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• NovoCare direct-pay program (FDA-approved Wegovy® pricing): novocare.com
• Cora Health Best Compounded Semaglutide Providers 2026 (national methodology): /blog/best-compounded-semaglutide-providers-2026